Studies on Anti-inflammatory Activity of Crude Aqueous Extract of Clerodendron fragrans in Experimental Animals
Journal: International Journal of Pharmaceutical Sciences Letters (Vol.2, No. 2)Publication Date: 2012-01-04
Authors : Srinivasana Krishna P. Bhatta Shanmugam S. Kumara Anbu Ja Rajarajan A.Tb K.K. Pillaic S.K. Sharmad; James B. Perianayagamd;
Page : 32-36
Keywords : Clerodendron fragrans; Verbenaceae; Carrageenan; cotton pellet-induced granuloma; Antiinflammatory;
Abstract
Background: Clerodendron species have medicinal value, the plant has been selected and the antiinflammatory activity of aqueous extract of Clerodendron fragrans (AECL) was evaluated in several experimental models in rats. Methods: The anti-inflammatory activity of the leaves of Clerodendron fragrans has been evaluated using carrageenan, formaldehyde, histamine and egg white-induced rat paw oedema and cotton pellet?induced granuloma models in rats. Results: The aqueous extract of Clerodendron fragrans (AECL) exhibited significant (p < 0.01) anti-inflammatory activity in acute and chronic inflammatory animal models. At 500 mg/kg the aqueous extract exhibited maximum inhibition of 50.9% in carrageenan-induced rat paw oedema whereas the standard ibuprofen showed inhibition of 56.8% after 3 h of carrageenan challenge. The extract (250 and 500 mg/kg) exhibited significant (p < 0.01) antiinflammatory activity in formaldehyde, histamine and egg white- induced rat paw oedema. In the chronic model (cotton pellet induced granuloma), the AECL (500 mg/kg) produced maximum inhibition of 38.5% in granuloma weight compared with 44.0% reduction in granuloma weight for the standard. Conclusion: The aqueous extract of C. fragrans elicited pronounced anti-inflammatory activity in laboratory animals at the doses investigated
Other Latest Articles
- Comparative Study for the Egyptian and Malaysian Rosemary Water Extracts For their Active, Antioxidant and Anti-proliferative Contents
- Development and Validation of LCMS Method for the Estimation of Pramipexole in Human Plasma
- Novel Sustained Release Swellable Bioadhesive Floating Gastroretentive Drug Delivery System of Bilayer Tablets Containing Rifampicin and Isoniazid
- Transdermal Patches of Ramipril an Attempt to Improve Patient Compliance
- Stable and Bio-equivalent Formulation of HMG-CoA reductase inhibitor: Atorvastatin Calcium
Last modified: 2013-06-03 17:35:06